Pre-filled asthma pen approved for self-administration in EU
Tezspire is the first biologic approved in Europe for severe asthma with no phenotype or biomarker limitation, says AstraZeneca EVP.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
